Safety and Pharmacokinetic Study of Tenofovir Alafenamide (TAF)/Elvitegravir (EVG) Administered Rectally
Clinical trial NCT04047420 · COMPLETED
Trial details
- NCT number
- NCT04047420
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-11
- Primary completion
- 2021-03-03
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.